Aurotech Launches Drug Lifecycle Tracking Solution
The solution, DLTA, is built on a project-management platform overlaid with knowledge of drug development and FDA requirements.
Aurotech, Inc., an established management and IT consulting firm is entering the pharmaceutical market with the launch of its Drug Lifecycle Tracking Application (DLTA). DLTA is built on a project-management platform overlaid with knowledge of drug development and FDA requirements. The result is custom-mapped workflow management for the entire drug development lifecycle. Users have the ability to track, manage and monitor projects from centralized dashboards and in-system collaboration for hand-offs between teams.
For CROs, DLTA can be implemented to improve clinical trial workflows across large teams or projects. For a pharmaceutical organization, the solution can function as an end-to-end work management platform, to replace disparate systems.
Read the full release.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
